ESC 365 - Prasugrel based de-escalation of antiplatelet treatment in patients with acute coronary syndrome undergoing percutaneous coronary intervention: results from the HOST-REDUCE-POLYTECH-ACS trial

ESC Premium Access

Prasugrel based de-escalation of antiplatelet treatment in patients with acute coronary syndrome undergoing percutaneous coronary intervention: results from the HOST-REDUCE-POLYTECH-ACS trial

Session: Latest Randomized Results on Antiplatelet Therapy

Topic: Pharmacotherapy

Speaker: Doctor H. Kim (Seoul, KR)

Event: ESC Congress 2020

Congress Presentation

About the speaker

Doctor Hyo-Soo Kim

Seoul National University Hospital, Seoul (Korea (Republic of))

5 presentations

0 follower

3 more presentations in this session

Online session - Latest Randomized Results on Antiplatelet Therapy - Host and Discussant

Speaker: Professor M. Roffi (Geneva, CH)

The effect of one year postoperative ticagrelor in addition to aspirin on saphenous vein graft patency in patients undergoing CABG – a randomized, multi-center, double-blind, placebo-controlled trial.

Speaker: Miss L. Willemsen (Nieuwegein, NL)

Downstream or upstream P2Y12 receptor blockers in NSTE-ACS

Speaker: Associate Professor G. Tarantini (Padova, IT)

Access the full session

Latest Randomized Results on Antiplatelet Therapy

Speakers: Doctor H. Kim, Professor M. Roffi, Miss L. Willemsen, Associate Professor G. Tarantini

About the event

ESC Congress 2020

29 August - 1 September 2020

Sessions Presentations

Congress

ESC 365 is supported by